Laboratory and Surveillance – a key Area of Work under the PIP Framework Partnership Contribution (PC) Implementation Plan 2013-2016
Through 2016, the majority of PIP Framework funds for preparedness will be used to strengthen laboratory and surveillance capacities in countries where such capacities are weak. This enables WHO/Europe to enhance its existing support to Member States in this area of work.
The Laboratory and Surveillance activities will lead to improved:
- national capacities to detect, assess and respond to an influenza pandemic or outbreaks of severe acute respiratory infections (SARI) due to a novel virus;
- national capacities to monitor trends in circulating influenza viruses;
- global collaboration, through the sharing of information and viruses (epidemiological data from sentinel surveillance and PCR detection quality assurance).
Support for eligible Member States in the European Region
WHO/Europe is working with these Member States to:
- increase the capacity of laboratories to detect influenza viruses and to share influenza viruses with WHO Collaborating Centres for Reference and Research on Influenza;
- achieve WHO recognition of National Influenza Centres in Armenia, Tajikistan, Turkmenistan and Uzbekistan;
- strengthen sentinel influenza surveillance for influenza-like illness and SARI;
- enhance national capacities to respond to outbreaks of respiratory infections;
- develop national clinical guidelines for treatment of SARI cases;
- enhance collaboration between stakeholders involved in influenza surveillance, and those involved in the animal and human influenza sectors.
In addition to country-specific activities, the PIP Framework PC enables WHO/Europe to enhance its support to the Region-wide influenza surveillance network.
The main activities conducted for the network in 2014 were:
- a joint WHO/Europe and ECDC annual influenza surveillance meeting (11–13 June 2014 in Vienna, Austria);
- development and publication of a new joint WHO/Europe and ECDC influenza bulletin – FluNews Europe;
- laboratory training in genetic sequencing in collaboration with the Global Initiative for Sharing All Influenza Data (GISAID) and training in laboratory quality and biosafety.